To evaluate the clinical effect of ultrasound-guided laser ablation therapy of prostate cancer.
Methods:
The data of long-term follow-up of one case of prostate cancer who underwent ultrasound-guided transperineal laser ablation were retrospectively analyzed and the related literatures were reviewed.
Results:
No serious side effects occurred during and after the surgery. During the two-year follow-up
prostate-specific antigen (PSA) level gradually reduced to and maintained at a relatively low level
and the imaging results showed no sign of recurrence.
Conclusion:
Ultrasound-guided laser ablation therapy of prostate cancer is a promising treatment strategy
but large sample
multi-center and prospective studies are still needed to evaluate its safety and efficacy.
Intratumoural and peritumoural mpMRI-based Delta-radiomics model for the prediction of the response to androgen deprivation therapy in prostate cancerLI Rong1, WANG Ting1, LÜ Hong2, LIU Xiaohang1, ZHOU Liangping1, GU Yajia1, ZHOU Bingni1
Evaluation of prostate cancer across different treatment stages using 18F-FDG PET imaging
A comparative study of 68Ga-TBM-001 PET/CT and 99mTc-MDP bone scintigraphy in the diagnosis of bone metastases of prostate cancer
Advances in the application of ultrasound artificial intelligence in prostate cancer
The value of transrectal ultrasound fusion with mpMRI navigation combined with elastography-guided targeted prostate biopsy
Related Author
李榕
王婷
吕泓
刘晓航
周良平
顾雅佳
周冰妮
Chu WANG
Related Institution
Department of Pathology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Department of Radiology, Fudan University Shanghai Cancer Center, Department of Oncology, Shanghai Medical College, Fudan University
Clinical Medicine, Peking Union Medical College, Chinese Academy of Medical Sciences
Department of Nuclear Medicine, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
Department of Radiology, Chengdu Seventh People’s Hospital, Affilitated Cancer Hospital of Chengdu Medical College